Bloomios Financials

BLMS Stock  USD 0.0001  0.00  0.00%   
We suggest to use Bloomios fundamental analysis to find out if markets are presently mispricing the company. Put another way you can use it to find out if Bloomios is indeed mispriced or if you can make any profits on it by purchasing it and then waiting for the market to recognize its mistake and reprise the security. We have collected data for twenty-four available fundamental indicators for Bloomios, which can be compared to its peers. The stock experiences a normal downward fluctuation but is a risky buy. Check odds of Bloomios to be traded at $1.0E-4 in 90 days.
  
Understanding current and past Bloomios Financials, including the trends in assets, liabilities, equity and income are directly related to making proper and timely investing decisions. All of Bloomios' financial statements are interrelated, with each one affecting the others. For example, an increase in Bloomios' assets may result in an increase in income on the income statement.
Please note, the imprecision that can be found in Bloomios' accounting process means that the reasonable investor should take a skeptical approach toward the financial statement analysis of Bloomios. Check Bloomios' Beneish M Score to see the likelihood of Bloomios' management manipulating its earnings.

Bloomios Stock Summary

Bloomios, Inc. manufactures, markets, and distributes cannabidiol products. Bloomios, Inc. was incorporated in 2001 and is headquartered in Santa Barbara, California. Bloomios is traded on OTC Exchange in the United States.
InstrumentUSA Pink Sheet View All
ExchangePINK Exchange
ISINUS0948571098
Business Address201 West Montecito
SectorHealthcare
IndustryDrug Manufacturers—Specialty & Generic
BenchmarkDow Jones Industrial
Websitewww.bloomios.com
Phone805 222 6330
CurrencyUSD - US Dollar

Bloomios Key Financial Ratios

There are many critical financial ratios that Bloomios' investors are exposed to on a daily basis, but they are usually grouped into few meaningful categories from each financial statement that Bloomios reports annually and quarterly.

Bloomios Financial Ratios Relationships

Comparative valuation techniques use various fundamental indicators to help in determining Bloomios's current stock value. Our valuation model uses many indicators to compare Bloomios value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Bloomios competition to find correlations between indicators driving Bloomios's intrinsic value. More Info.
Bloomios is number one stock in return on asset category among its peers. It also is number one stock in profit margin category among its peers . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Bloomios' earnings, one of the primary drivers of an investment's value.

Additional Tools for Bloomios Pink Sheet Analysis

When running Bloomios' price analysis, check to measure Bloomios' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Bloomios is operating at the current time. Most of Bloomios' value examination focuses on studying past and present price action to predict the probability of Bloomios' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Bloomios' price. Additionally, you may evaluate how the addition of Bloomios to your portfolios can decrease your overall portfolio volatility.